Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Long-Term Deferred Tax (2023 - 2025)

Outset Medical has reported Long-Term Deferred Tax over the past 3 years, most recently at $1.2 million for Q4 2025.

  • Quarterly Long-Term Deferred Tax rose 17.07% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, up 17.07% year-over-year, with the annual reading at $1.2 million for FY2025, 17.07% up from the prior year.
  • Long-Term Deferred Tax was $1.2 million for Q4 2025 at Outset Medical, up from $990000.0 in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $1.3 million in Q4 2023 and troughed at $990000.0 in Q4 2024.
  • The 3-year median for Long-Term Deferred Tax is $1.2 million (2025), against an average of $1.2 million.
  • Year-over-year, Long-Term Deferred Tax fell 26.28% in 2024 and then increased 17.07% in 2025.
  • A 3-year view of Long-Term Deferred Tax shows it stood at $1.3 million in 2023, then fell by 26.28% to $990000.0 in 2024, then rose by 17.07% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Long-Term Deferred Tax are $1.2 million (Q4 2025), $990000.0 (Q4 2024), and $1.3 million (Q4 2023).